Close Menu

NEW YORK (GenomeWeb) – Sysmex, a Japanese in vitro diagnostics company, has signed a deal to acquire all the shares of Oxford Gene Technology, OGT said today.

Upon completion of the deal, OGT will become a wholly owned subsidiary of Sysmex. Further terms were not disclosed, though OGT CFO Tim Hall said that the deal is likely to close by mid-June.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

St. Jude Children's Research Hospital scientists have treated infants with X-linked severe combined immunodeficiency using gene therapy in an early phase study.

Bloomberg reports that the DNA-for-cash deal reported in Kentucky might be a more widespread scam.

St. Louis Public Radio reports that some African Americans are turning to DNA ancestry testing to help guide genealogical searches.

In Nature this week: a genomic analysis of the snailfish Pseudoliparis swirei, ancient DNA analysis gives insight into the introduction of farming to England, and more.